Who is sponsoring NCT04263103?

NCT04263103 is sponsored by Guangzhou Shijing Medical Software.

What drugs are being tested in NCT04263103?

Interventions in NCT04263103: SJ-RS-WL2015 visual training program software.

What condition does NCT04263103 study?

NCT04263103 studies Intermittent Exotropia.

Is NCT04263103 still recruiting?

NCT04263103 is currently status unknown. Last updated 10 February 2020.

Last reviewed 2020-02-10 · How we verify

NCT04263103

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Training Software (SJ-RS-WL2015) Rehabilitating Intermittent Exotropia Binocular Functions

Status unknown NA Last updated 10 February 2020

What this trial tests

NA trial testing SJ-RS-WL2015 visual training program software in Intermittent Exotropia in 92 participants. Status unknown.

Timeline

9 December 2019

Primary endpoint
31 October 2020

31 December 2020

Quick facts

Lead sponsor	Guangzhou Shijing Medical Software
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	92
Start date	9 December 2019
Primary completion	31 October 2020
Estimated completion	31 December 2020
Sites	2 locations across China

Drugs / interventions tested

SJ-RS-WL2015 visual training program software

Conditions studied

Intermittent Exotropia — all drugs for Intermittent Exotropia →

Sponsor

Guangzhou Shijing Medical Software

Who can join

Adults 5 to 16, any sex, with Intermittent Exotropia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluating the effect of SJ-RS-WL2015 visual training program in children with intermittent exotropia after eye surgery, including the improvement of simultaneous perception (I binocular function), fusion (II binocular function), stereopsis (III binocular function).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Interventions for intermittent exotropia.
Pang Y, Gnanaraj L, Gayleard J, Han G, et al · · 2021 · cited 31× · PMID 34516656 · DOI 10.1002/14651858.cd003737.pub4

Verify or expand the search:

Other Guangzhou Shijing Medical Software trials

Trials by the same sponsor.

NCT04238065 — A Clinical Trial of Caterna Virtual Reality Facilitating Treatment in Children With Amblyopia · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04263103 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Guangzhou Shijing Medical Software
Last refreshed: 10 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04263103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing